Skip to content

A Comparison of Intraocular Pressures (IOP) During Prolonged Trendelenburg Positioning in Morbidly Obese and Thin Patients

A Comparison of Intraocular Pressures (IOP) During Prolonged Trendelenburg Positioning in Morbidly Obese and Thin Patients

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01737645
Enrollment
4
Registered
2012-11-29
Start date
2012-08-31
Completion date
2014-07-31
Last updated
2014-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraocular Pressure Disorder

Brief summary

This study is to determine if there is a rise in eye pressure, when patients are placed in a position where the head is lower than the rest of the body during long surgeries.

Detailed description

Eye pressure will be measured at protocol specified intervals.

Interventions

None listed

Sponsors

Corewell Health East
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Subjects undergoing prolonged procedures (scheduled \>3hr) in steep Trendelenburg position (eg. robotic prostatectomy, hysterectomy, cystectomy) 2. Morbidly obese subjects: BMI ≥ 35 kg/m2 3. Thin subjects: BMI ≤ 30 kg/m2 4. Age 18-70 5. ASA (American Society of Anesthesiologists) physical status classification I, II, or III

Exclusion criteria

1. Known history of glaucoma 2. Note:if initial IOP is noted to be \>21mmHg (millimeters of mercury), patient will be excluded from study and an ophthalmology consultation will be obtained.Surgery will not be postponed. 3. Recent use of IOP lowering topical ophthalmic agents 4. Allergy to latex or proparacaine hydrochloride ophthalmic solution 5. Patients with active corneal epithelial defects or history of recurrent corneal erosion 6. Patients with underlying disorders that can directly increase intraocular pressure (thyroid eye disease, intra orbital tumors, orbital vascular malformation, Sturge-Weber disease, carotid or dural cavernous arteriovenous malformation, cavernous sinus pathology) 7. History of corneal surgery, to include LASIK (laser-assisted in-situ keratomileusis) 8. Any eye surgery within prior 1 month 9. Known pregnancy 10. Cognitive impairment

Design outcomes

Primary

MeasureTime frame
To compare the percent change from baseline IOP reading to the peak IOP reading during steep Trendelenburg positioning in thin subjects vs morbidly obese subjects.Measured from baseline IOP to peak IOP during steep Trendelenburg. The overall time frame for which the outcome measure is assessed is up to 3 years.

Secondary

MeasureTime frame
To determine rate of rise of IOP during steep Trendelenburg positioningThe time during the surgery when the patient is in steep Trendelenburg positioning. The overall time frame for which the outcome measure is assessed is up to 3 years.
To compare peak IOP and rise of IOP during steep Trendelenburg positioning in thin vs morbidly obese subjects.The time during the surgery when the patient is in steep Trendelenburg positioning. The overall time frame for which the outcome measure is assessed is up to 3 years.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026